AIM at Melanoma Foundation

The AIM at Melanoma Foundation (AIM) is a nonprofit organization focused on melanoma research.

AIM was created as a collaboration between the Charlie Guild Foundation and James A. Schlipmann Melanoma Cancer Foundation.

Activities
AIM is a partner of the Society for Immunotherapy of Cancer.

Sponsors
In the first quarter of 2021, the foundation received a $10,000 grant from Pfizer for a project titled “From the Clinic to the Living Room”. Additional industry sponsors include:

• Alkermes

• Amgen

• BioNTech

• Bristol-Myers Squibb

• Genentech

• Genzyme

• Immunocore

• Iovance Biotherapeutics

• Merck

• Myriad Genetics

• Natera

• Novartis

• Pfizer

• Pierre Fabre Group

• Regeneron Pharmaceuticals

• Roche